Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter.

NCT01270152 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01270152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Determining the Safe Dosage of Ascorbic Acid Used in the Treatment of Occluded Totally Implanted Central Venous Catheter.
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2008
Completion date
July 31, 2010
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

occluded totally implanted central venous catheter